# A new era in neuroregeneration | Annie Kathuria | TEDxBoston Source: https://www.youtube.com/watch?v=7cm50VEesrk Recap page: https://rapidrecap.app/video/7cm50VEesrk Generated: 2025-11-21T17:39:02.411+00:00 --- ## Quick Overview Annie Kathuria presents a multi-stage plan, "Crossing the Transplantable Gap," to advance the field of neuroregeneration for Traumatic Brain Injury (TBI) by creating transplantable brain organoids that integrate and function within a host, moving from bench research to preclinical trials and eventually to the bedside. **Key Points:** - TBI affects over 20 million people worldwide annually, leaving 55 million living with TBI-related disabilities, often with the grim prognosis that the brain cannot regenerate. - The research focuses on overcoming the transplantable gap by developing transplantable brain organoids that integrate with host tissues, including the formation of blood vessels and electrical function. - The multi-step plan ("Crossing the Transplantable Gap") involves eight stages: 1) iPSC Protocols & Master Bank-Transplant lines (GMP/GLP), 2) Cell Lineage-Relevance, 3) Omics ECM/Signals Identification, 4) Radial Glia BM Attachment, 5) Multi-Region Integration, 6) Cell Viability (Mean by Marker), 7) Early BBB Formation, Vascular and Electrical Function, and 8) Transport and Storage. - The team demonstrated that their organoids possess both cerebral and endothelial components (01:51) and exhibit key functional milestones like vascular network formation and electrical signaling (04:08, 05:50). - Preclinical models, both small (e.g., open field and touchscreen testing) and large (using an electromagnetic impactor for TBI modeling), are being used to validate safety, viability, and functional recovery (06:19, 06:43). - The ultimate call to action is collaborative, involving tissue engineers, biomaterials experts, and neurosurgeons to move GMP-grade, clinically compatible iPSC cell lines through preclinical trials towards FDA readiness (07:01). ![Screenshot at 00:33: The title slide clearly frames the presentation around Traumatic Brain Injury \(TBI\) and the central, difficult question: "Will I ever recover?", juxtaposed with a stark illustration of affected individuals and statistics indicating 20 million new cases yearly.](https://ss.rapidrecap.app/screens/7cm50VEesrk/00-00-33.png) **Context:** Annie Kathuria delivers a TEDxBoston talk addressing the severe challenge of Traumatic Brain Injury (TBI), highlighting the devastating question patients face: "Will I ever recover?" because the brain typically cannot regenerate. She introduces her team's ambitious research program focused on regenerative medicine, specifically using induced pluripotent stem cells (iPSCs) to grow complex, transplantable brain organoids that could eventually replace damaged neural tissue and restore function. ## Detailed Analysis Annie Kathuria begins by framing the gravity of Traumatic Brain Injury (TBI), noting that it affects over 20 million people annually worldwide, with 55 million living with disabilities, and the current answer to recovery is often "probably not" because the brain doesn't regenerate like other organs. She pivots the discussion by posing the essential question: "What if we could regrow the human?" She asserts that growing transplantable brain organoids is within reach in our lifetime. She details an eight-step roadmap, "Crossing the Transplantable Gap," designed to bridge the gap between bench science and clinical transplantation. This roadmap includes establishing GMP/GLP iPSC protocols, ensuring cell lineage relevance, identifying critical signaling molecules (Omics), achieving radial glia basement membrane attachment, integrating multiple brain regions, verifying cell viability, confirming early blood-brain barrier (BBB) formation and electrical function, and establishing transport/storage protocols (01:52-06:07). Visual data supports this, showing the differentiation of iPSCs into cortical and endothelial cell types, forming a structure that exhibits the necessary six cortical layers and functional vasculature (01:16, 02:38). Preclinical testing involves small models using behavioral tasks like the Open Field test and touchscreen cognition tests, showing improved performance after injury treatment (06:19). Large animal models utilize an electromagnetic impactor to induce TBI, which is verified via ultrasound imaging showing dura violation and pooling of blood (06:42). Finally, she emphasizes that the integrated organoid structure exhibits electrical function and communicates across regions, demonstrating functional maturity necessary for transplantation, concluding with a call to action for collaboration to move these transplantable lines from the bench through preclinical trials to FDA readiness (07:01). ### Introduction to TBI and the Recovery Question - Will I ever recover? - TBI affects 20 million people annually worldwide - Current answer is "probably not" because the brain cannot regenerate - Speaker proposes regrowing the human brain via organoids (00:04-00:44) ### Crossing the Transplantable Gap - 8 Steps: 1. iPSC Protocols & Master Bank-Transplant lines (GMP/GLP) - 2. Cell Lineage-Relevance - 3. Omics ECM/Signals Identification - 4. Radial Glia BM Attachment - 5. Multi-Region Integration - 6. Cell Viability (Mean by Marker) - 7. Early BBB Formation, Vascular And Electrical Function - 8. Transport and Storage (01:52-06:07) ### Organoid Development and Validation - Differentiation protocol shown moving from iPSC to cortical/endothelial structures over 20 days - Organoid structure shows six cortical layers and vascular networks (Nestin Cux1 CD31 markers) - Transcriptomic data confirms expression of various cell markers (02:38-03:42) ### Preclinical Testing - Small Models: Open Field test shows reduced latency to center entry post-treatment - Touchscreen testing demonstrates improved attentional control (5-choice passing rate) across varying difficulty levels (06:19-06:40) ### Preclinical Testing - Large Models & Injury Validation: Electromagnetic impactor used to model TBI in large models - Ultrasound imaging confirms injury markers like dura violation and pooling of blood (06:42-06:56) ### Functional Integration and Future - Transplanted organoids integrate with host tissue, showing electrical function and vascular network communication - The goal is transplantable lines ready for Phase 1 studies within five years (06:58-07:38) ### Call to Action - Need collaboration between tissue engineers, biomaterials scientists, and neurosurgeons - Move GMP-grade iPSC lines from Bench to Preclinical Trials to Bedside/Regulatory Pathway (07:01-07:21) ![Screenshot at 00:33: The title slide clearly frames the presentation around Traumatic Brain Injury \(TBI\) and the central, difficult question: "Will I ever recover?", juxtaposed with a stark illustration of affected individuals and statistics indicating 20 million new cases yearly.](https://ss.rapidrecap.app/screens/7cm50VEesrk/00-00-33.png) ![Screenshot at 01:18: Slide asking "What if we could regrow the human?" alongside a fluorescent image of a brain organoid \(1mm in size\) showing cortical and endothelial cell populations \(pink and green\).](https://ss.rapidrecap.app/screens/7cm50VEesrk/00-01-18.png) ![Screenshot at 02:38: Slide detailing the 8 steps to "Crossing the Transplantable Gap," showing the organoid differentiation timeline and a UMAP plot illustrating the emergence of various cerebral cell types.](https://ss.rapidrecap.app/screens/7cm50VEesrk/00-02-38.png) ![Screenshot at 06:23: Slide detailing "Preclinical Small Models" showing apparatus for Open Field testing \(trajectory plots\) and Touchscreen testing, along with a bar chart showing improved attentional control post-treatment.](https://ss.rapidrecap.app/screens/7cm50VEesrk/00-06-23.png) ![Screenshot at 07:01: The final slide outlines the "Call to Action" roadmap, showing the progression from GMP-grade iPSC lines \(Bench\) through Small and Large Models \(Preclinical Trials\) toward Regulatory Pathway/Bedside readiness, requiring collaboration from engineers and surgeons.](https://ss.rapidrecap.app/screens/7cm50VEesrk/00-07-01.png)